Created by CG Life, 24/364 is a new cultural brand platform bringing year-round visibility to the lived experience of rare disease. Designed to extend the impact of Rare Disease Day, 24/364 will include a “day-in-the-life” video series profiling amazing families affected by rare diseases. Plans are also underway to hold the 24/364 Rare Disease Film Festival in early 2027, inviting amateur and professional filmmakers to share their stories with the world.
In Med Ad News’ Agenda 2026, CG Life EVP of Business Development Jay Carter explores the forces shaping healthcare marketing in the year ahead — from affordability and regulation to AI, omnichannel evolution, and the changing nature of agency partnerships.
For rare disease and precision medicine brands, the message is clear: success in 2026 will require smarter orchestration, deeper human insight, and true partnership.
Our “Locals” campaign earned Silver in the Self-Promotion/Corporate Campaign category at the 17th Annual PM360 Pharma Choice Awards.
“Locals” reframed our story around hard-earned expertise in rare disease and precision medicine—grounded in science, shaped by digital fluency, and built through years navigating rare territory. Voted on by industry peers, the Pharma Choice Awards recognize standout creative across healthcare and life sciences
